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Background-—Takotsubo syndrome (TTS) is an acute reversible heart condition initially believed to represent a benign pathology
attributable to its self-limiting clinical course; however, little is known about its prognosis based on different triggers. This study
compared short- and long-term outcomes between TTS based on different triggers, focusing on various physical triggering events.
Methods and Results-—We analyzed patients with a definitive TTS diagnosis recruited for the Spanish National Registry on TTS
(RETAKO [Registry on Takotsubo Syndrome]). Short- and long-term outcomes were compared between different groups according
to triggering factors. A total of 939 patients were included. An emotional trigger was detected in 340 patients (36.2%), a physical
trigger in 293 patients (31.2%), and none could be identified in 306 patients (32.6%). The main physical triggers observed were
infections (30.7%), followed by surgical procedures (22.5%), physical activities (18.4%), episodes of severe hypoxia (18.4%), and
neurological events (9.9%). TTS triggered by physical factors showed higher mortality in the short and long term, and within this
group, patients whose physical trigger was hypoxia were those who had a worse prognosis, in addition to being triggered by
physical factors, including age >70 years, diabetes mellitus, left ventricular eyection fraction <30% and shock on admission, and
increased long-term mortality risk.
Conclusions-—TTS triggered by physical factors could present a worse prognosis in terms of mortality. Under the TTS label, there
could be as yet undiscovered very different clinical profiles, whose differentiation could lead to individual better management, and
therefore the perception of TTS as having a benign prognosis should be generally ruled out. ( J Am Heart Assoc. 2019;8:e013701.
DOI: 10.1161/JAHA.119.013701.)
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S ince its first description in Japan in 1990,
1 Takotsubo
syndrome (TTS), also known as stress cardiomyopathy,
has emerged as an important form of transient ventricular
systolic dysfunction that mimics an acute myocardial infarc-
tion, without evidence of complicated coronary artery dis-
ease.2 Although the global pathophysiology of this syndrome
is still unclear, it seems that the sympathetic neurohormonal
axis plays a key role, and several pathogenic theories have
been suggested.3 Some of the most globally postulated
include coronary vasospasm, endothelial dysfunction, cate-
cholamine-mediated toxicity, and alterations at the level of
the hypothalamic-pituitary-adrenal axis.4–9
In several cases, emotional stress can be evidenced as a
trigger that has led to the popular term “broken heart
syndrome.”10 Some researchers propose a classification of
patients according to the nature of the trigger, and as such, this
emotionally triggered TTS should be considered TTS, whereas
other cases with similar clinical conditions, but triggered by
physical factors (surgery, hemorrhages, infections, etc), should
be considered “Takotsubo-like syndrome” instead.11 However,
the Mayo Clinic criteria, modified in 2008, include all patients in
the spectrum of global TTS, regardless of the nature of the
triggering factor.10 Our group has proposed a TTS classification
based on the triggers, differentiating between primary (trig-
gered by psychological stress or without an identifiable trigger)
and secondary forms (precipitated by physical factors).12 This is
of the utmost importance, because secondary TTS could
present a worse short- and long-term prognosis in terms of
mortality, recurrences, and readmissions.12 Recently, a classi-
fication for TTS has been proposed based on its possible
prognostic implications, extracted from the InterTAK (Interna-
tional Takotsubo) registry.13 However, the prognostic impact of
this classification has not been confirmed in external cohorts
that allow its usefulness to be validated. On the basis of this, we
propose this study, which infers the idea of the prognostic
importance of triggers in TTS.
Methods
The data that support the findings of this study are available
from the corresponding author upon reasonable request.
Patients and Inclusion Criteria
The National Multicenter RETAKO (Registry on Takotsubo
Syndrome) trial, supported by the Ischemic Heart Disease and
Acute Cardiovascular Care Section of the Spanish Society of
Cardiology, is a partially retrospective and prospective (from
January 1, 2012 onward) voluntary observational registry that
enrolled TTS patients from 38 centers in Spain. Its rationale
and design have been previously described.14 Main inclusion
criteria required a definitive TTS diagnosis (at hospital
discharge or within the first 6 months of follow-up) based
on the modified Mayo Clinic criteria.10
The present study included data from subjects with a
definitive TTS diagnosis between January 1, 2003 and July 31,
2018. Final date of follow-upwas July 31, 2018. Baseline patient
characteristics, triggering factors, in-hospital course, pharma-
cological treatment dispensed at the discretion of the attending
physician, and short- and long-term outcomes were captured
through a dedicated electronic case report form. The study
complied with the Declaration of Helsinki and was approved by
the Institutional Ethics Committee of Hospital Clinico San
Carlos. All patients provided written informed consent.
Types of Triggers
All the possible triggers in each patient were collected and
detailed and subsequently grouped into emotional, physical, or
unknown stress. These are predefined variables in the registry
that were included by the associated researchers of each of the
participating centers according to the patient’smedical history.
Two researchers independently checked these data. Those
patients presenting with physical stress were further stratified
in 5 cohorts: infectious, neurological disorders, surgical/
intervention, extreme physical activity/trauma, or hypoxia.
ECG and Echocardiographic Alterations
ECG variables are included in the registry database and
include the following: rhythm on admission, affected wall,
Clinical Perspective
What Is New?
• Our data confirm that the prognosis of patients with
Takotsubo syndrome is clearly influenced by the type of
trigger.
• Patients with an emotional trigger have a better prognosis,
whereas those with physical stress have the worst.
• Not all physical triggers influence the prognosis of patients
in the same way, with triggering by hypoxia presenting a
worse evolution in the short and long term.
What Are the Clinical Implications?
• Patients with Takotsubo syndrome related to physical stress
could present a worse short- and long-term prognosis in
terms of mortality.
• Therefore, these patients might be considered for surveil-
lance and additional management not only during hospital-
ization, but also during follow-up.
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initial ST-segment elevation, initial ST-segment depression,
initial negative T-wave, ST-segment elevation during hospital
stay, ST-segment depression during hospital stay, negative T-
wave during hospital stay, and maximum QTc interval during
hospital stay.
The pattern of LV dysfunction, based on angiography or
echocardiographic evaluation, was classified as follows:
1. Apical type: This type is characterized by hypo-, a-, or
dyskinesia of midventricular and apical parts of the
anterior, septal, inferior, and lateral walls of the left
ventricle, associated with hyperkinesia of basal segments.
2. Midventricular type: This type comprises hypo-, a-, or
dyskinesia of midventricular segments, most often like a cuff,
with normo- or hyperkinesia of basal and apical segments.
3. Basal type: This type involves hypo-, a-, or dyskinesia of
basal segments and normo- or hyperkinesia of midven-
tricular and anterior as well as anteroseptal and/or
anteroapikal segments of the left ventricle. This basal
type shows wall-motion abnormalities complementary to
the apical type, and as such, the basal type is also referred
to as the “inverse” form of takotsubo cardiomyopathy.
4. Focal type: This type is characterized by focal hypo-, a-, or
dyskinesia of any segment of the left ventricle. In most
cases, an anterolateral segment is involved.
Outcomes
We analyzed the occurrence of the following complications
during hospitalization:
1. Severe heart failure, defined as acute pulmonary edema or
cardiogenic shock.
2. Moderate or severe acute functional mitral regurgitation.
3. Dynamic left ventricular outflow tract obstruction.
Obstructions were determined echocardiographically or
from catheter pressure recordings; peak gradients
>25 mm Hg were considered significant.
4. Others: intraventricular thrombus formation, systemic
embolism and stroke, pulmonary thromboembolism, acute
renal failure, catheterization complications, and in-hospital
death.
Cardiovascular death was defined as death resulting from
myocardial infarction, sudden cardiac death, heart failure, or
other cardiovascular causes (peripheral arterial disease,
cerebrovascular or aortic disease, pulmonary embolism, or
cardiovascular bleeding). Any death not covered by this
definition was classified as noncardiovascular. Follow-up after
hospital discharge was conducted either by outpatient clinical
visits or structured telephone interviews with patients or
relatives. Follow-up outcomes were prespecified and defined
as the occurrence of all-cause death (including cardiovascular
or noncardiovascular mortality). If a prespecified outcome was
observed, review of electronic medical records and consensus
of 2 experienced local investigators was mandatory for event
adjudication. Patients who did not experience the outcome of
interest and those lost to follow-up were censored at the time
of the last contact.
Statistical Analysis
Statistical analysis was performed with the IBM SPSS
software package (version 20.0; IBM Corpp., Armonk, NY).
Continuous variables are expressed as mean and SD, and
differences were analyzed by the Student t test or the
Wilcoxon rank-sum test for non-normal distribution. Categor-
ical variables are expressed as frequency and percentage and
were compared by the chi-square test. Outcome analysis was
performed using Kaplan–Meier estimates and log-rank test, as
well as a landmark analysis set at 90 days. Cox regression
analysis was conducted to determine the hazard ratio and
95% CIs for long-term outcomes according to triggering
factors using emotional stressor as a reference. To account
for differences in baseline clinical characteristics and comor-
bidities between different TTS groups, a multivariable adjust-
ment analysis, including covariates with a univariate P<0.1 or
were likely to have a relationship to long-term mortality, was
performed in a Cox regression model. Differences were
considered significant at a 2-tailed P<0.05.
Results
A definite emotional stressor was detected in 340 patients
(36.2%). A trigger factor could not be identified in 306
patients (32.6%), whereas 293 patients had a physical factor
as a trigger (31.2%). Within the last group, the causes that
triggered the syndrome were infection in 90 patients (30.7%),
surgery in 66 patients (22.5%), trauma or extreme physical
activity in 54 patients (18.4%), hypoxic conditions in 54
patients (18.4%), and neurological disorder in 29 patients
(9.9%). Median follow-up of the cohort was 2.2 years
(interquartile range, 3.6).
Main patient characteristics of all different groups are
summarized in Tables 1 and 2. The prevalence of females
was significantly higher in TTS related to emotional stress
(93.5%) compared with the other groups. In the TTS group
related to physical stress, we found a higher frequency of
comorbidities such as lung disease, diabetes mellitus, and
renal failure. Within this group, we observed a greater mean
age in patients whose trigger was an infection (7511 years)
compared with the other groups. As expected, we observed a
greater percentage of chronic lung disease in the hypoxia
group.
DOI: 10.1161/JAHA.119.013701 Journal of the American Heart Association 3
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Female (%) 267 (87.3%) 318 (93.5%) 233 (79.5%) <0.001
Age, y 7212 7011 7113 0.067
Hypertension 188 (61.4%) 226 (66.5%) 190 (64.8%) 0.401
Dyslipidaemia 167 (54.6%) 158 (46.5%) 141 (48.1%) 0.099
Diabetes mellitus 94 (30.7%) 59 (17.4%) 67 (22.9%) <0.001
Smoker 103 (33.7%) 80 (23.5%) 101 (34.5%) 0.003
Lung disease 94 (30.7%) 58 (17.1%) 93 (31.7%) <0.001
Renal insufficiency 58 (19.0%) 13 (3.8%) 26 (8.9%) <0.001
TTS pattern 0.033
Apical 226 (86.6%) 278 (85.8%) 222 (77.6%)
Midventricular 16 (6.1%) 17 (5.2%) 35 (12.2%)
Basal 4 (1.5%) 4 (1.2%) 11 (3.8%)
Focal 15 (5.7%) 25 (7.7%) 18 (6.3%)
Clinical presentation
Chest pain 231 (75.5%) 305 (89.7%) 157 (53.6%) <0.001
Typical 193 (63.1%) 268 (78.8%) 118 (40.3%)
Atypical 38 (12.4%) 37 (10.9%) 39 (13.3%)
Vegetative symptoms 147 (48.0%) 170 (50.0%) 96 (32.8%) <0.001
Dyspnea 112 (36.6%) 128 (37.6%) 129 (44.0%) 0.131
Syncope 17 (5.6%) 26 (7.6%) 34 (11.6%) 0.024
Shock on admission 20 (6.5%) 14 (4.1%) 44 (15.0%) <0.001
ECG on admission
Sinus rhythm 231 (87.2%) 295 (89.7%) 236 (83.4%) 0.251
ST-segment elevation 103 (39.2%) 128 (39.1%) 132 (47.8%) 0.055
ST-segment depression 41 (15.6%) 46 (14.2%) 48 (17.6%) 0.524
T-wave inversion 100 (30.3%) 106 (32.7%) 117 (42.5%) 0.045
QTc, ms* 50471 49769 51065 0.211
LVEF, % 4313 4312 3912 <0.001
In-hospital complications
Max. Killip degree <0.001
I 220 (71.9%) 245 (72.1%) 153 (52.2%)
II 39 (12.7%) 47 (13.8%) 55 (18.8%)
III 24 (7.8%) 27 (7.9%) 32 (10.9%)
IV 23 (7.5%) 21 (6.2%) 53 (18.1%)
Death during admission 9 (2.9%) 5 (1.6%) 12 (4.1%) 0.211
Mitral regurgitation 21 (6.9%) 23 (6.8%) 19 (6.5%) 0.376
LVOT gradient† 16 (5.2%) 12 (3.5%) 3 (1.0%) 0.015
Systemic embolism 9 (2.9%) 6 (1.8%) 6 (2.0%) 0.051
Ventricular arrhythmias‡ 8 (2.6%) 8 (2.4%) 17 (5.8%) 0.004
Hospital stay, d 86 88 1316 <0.001
LVEF indicates, left ventricular ejection fraction; LVOT, left ventricular outflow tract; Max., maximum; N, number; TTS, Takotsubo syndrome.
*QTc maximum during admission.
†Defined as a peak gradient >25 mm Hg without inotropics.
‡Ventricular arrhythmias that need treatment.
DOI: 10.1161/JAHA.119.013701 Journal of the American Heart Association 4


















 http://ahajournals.org by on January 25, 2021
Table 2. Clinical Characteristics of Different Physical Triggering Groups
Sepsis (N=90)
Neurological
Disorders (N=29) Surgery (N=66)
Extreme Physical
Activity/Trauma (N=54) Hypoxia (N=54) P Value
Female (%) 74 (82.2%) 22 (75.9%) 51 (77.3%) 48 (88.9%) 38 (70.4%) 0.163
Age, y 7511 7012 6714 7312 6815 0.001
Hypertension 65 (72.2%) 18 (62.1%) 37 (56.1%) 36 (66.7%) 34 (63.0%) 0.326
Dyslipidemia 42 (46.7%) 17 (58.6%) 28 (42.4%) 28 (51.9%) 26 (48.1%) 0.642
Diabetes mellitus 23 (25.6%) 6 (20.7%) 11 (16.7%) 14 (25.9%) 13 (24.1%) 0.696
Smoker 31 (34.4%) 8 (27.6%) 24 (36.4%) 11 (20.4%) 27 (50.0%) 0.024
Lung disease 38 (42.4%) 3 (10.3%) 19 (28.8%) 9 (16.7%) 24 (44.4%) <0.001
Renal insufficiency 9 (10.0%) 1 (3.4%) 4 (6.1%) 5 (9.3%) 7 (13.0%) 0.563
TTS pattern 0.015
Apical 75 (83.3%) 21 (72.4%) 43 (67.2%) 42 (80.8%) 41 (80.4%)
Midventricular 8 (8.9%) 2 (6.9%) 16 (25.0%) 5 (9.6%) 4 (7.8%)
Basal 3 (3.3%) 4 (13.8%) 1 (1.6%) 0 (0.0%) 3 (5.9%)
Focal 4 (4.4) 2 (6.9%) 4 (6.2%) 5 (9.6%) 3 (5.9%)
Clinical presentation
Chest pain 49 (54.5%) 11 (37.9%) 27 (40.9%) 38 (70.4%) 32 (59.3%) 0.035
Typical 34 (37.8%) 7 (24.1%) 21 (31.8%) 30 (55.6%) 26 (48.1%)
Atypical 15 (16.7%) 4 (13.8%) 6 (9.1%) 8 (14.8%) 6 (11.1%)
Vegetative symptoms 30 (33.3%) 6 (20.7%) 21 (31.8%) 25 (46.3%) 14 (25.9%) 0.108
Dyspnea 61 (67.8%) 6 (20.7%) 26 (39.4%) 13 (24.1%) 23 (42.6%) <0.001
Syncope 5 (5.6%) 7 (24.1%) 10 (15.2%) 5 (9.3%) 7 (13.0%) 0.065
Shock on admission 16 (17.8%) 1 (3.4%) 9 (13.6%) 6 (11.1%) 12 (22.2%) 0.164
ECG on admission
Sinus rhythm 70 (83.3%) 23 (79.3%) 51 (78.5%) 47 (90.4%) 45 (84.9%) 0.491
ST-segment elevation 48 (59.3%) 14 (51.9%) 31 (48.4%) 28 (54.9%) 23 (43.4%) 0.437
ST-segment depression 9 (11.2%) 6 (22.2%) 12 (19.4%) 8 (16.0%) 13 (24.5%) 0.332
T-wave inversion 39 (48.8%) 13 (46.4%) 28 (44.4%) 20 (39.2%) 17 (32.1%) 0.338
QTc, ms* 52165 48946 50761 49268 52273 0.171
LVEF, % 3711 4212 3812 4211 4011 0.054
In-hospital complications
Max. Killip degree 0.071
I 38 (42.4%) 20 (69.0%) 31 (47.0%) 34 (63.0%) 30 (55.6%)
II 23 (25.6%) 3 (10.3%) 10 (15.2%) 10 (18.5%) 9 (16.7%)
III 12 (13.3%) 5 (17.2%) 9 (13.6%) 3 (5.6%) 3 (5.6%)
IV 17 (18.9%) 1 (3.4%) 16 (24.2%) 7 (13.0%) 12 (22.2%)
Death during admission 2 (2.2%) 2 (6.9%) 2 (3.0%) 1 (1.9%) 5 (9.3%) 0.204
Mitral regurgitation 5 (5.6%) 1 (3.4%) 4 (6.1%) 7 (13.0%) 2 (3.7%) 0.286
LVOT gradient† 0 (0.0%) 0 (0.0%) 0 (0.0%) 2 (3.7%) 1 (1.9%) 0.191
Systemic embolism 1 (1.1%) 3 (10.3%) 1 (1.5%) 0 (0.0%) 1 (1.9%) 0.021
Ventricular arrhythmias‡ 4 (4.4%) 2 (6.9%) 8 (12.1%) 1 (1.9%) 2 (3.7%) 0.014
Hospital stay, d 1312 1416 1418 1111 1522 0.722
LVEF indicates left ventricular ejection fraction; LVOT, left ventricular outflow tract; Max., maximum; N, number; TTS, Takotsubo syndrome.
*QTc maximum during admission.
†Defined as a peak gradient >25 mm Hg without inotropics.
‡Ventricular arrhythmias that need treatment.
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Regarding debut symptoms, typical chest pain and vege-
tative symptoms were more prevalent in the TTS related to
emotional stress group, whereas syncope and dyspnea were
more common in the TTS related to physical stress group. In
the latter group, we found a higher percentage of typical chest
pain in patients whose physical trigger was exercise or
trauma, whereas a greater percentage of syncope was evident
in TTS triggered by neurological disorders.
We found a higher percentage of apical morphology in the
TTS related to emotional stress and TTS without any identifiable
trigger groups (primary forms). Midventricular and basal types
was more frequent in patients with physical stress, and rate of
focal pattern was similar in all 3 groups. In the TTS related to
physical stress group (or secondary forms), apical forms were
more frequently observed in the infection and physical activity/
trauma groups, whereas midventricular morphology was
Figure 1. Kaplan–Meir survival landmark analysis by triggering events. A, All-cause death. B, Cardiovascular death.
Figure 2. Kaplan–Meir survival landmark analysis by physical triggering events. A, All cause of mortality. B, Cardiovascular mortality. No.
indicates number.
DOI: 10.1161/JAHA.119.013701 Journal of the American Heart Association 6


















 http://ahajournals.org by on January 25, 2021
predominant in TTS triggered by surgery procedures and the
basal or inverse pattern predominated in TTS patients with
neurological disorders. Finally, the focal pattern was more
frequent in the physical activity or trauma group.
Patients with TTS related to physical stress had a longer
hospital stay than patients with primary forms. In these
patients, a greater number of in-hospital complications
occurred, mainly a higher incidence and severity of heart
failure and a higher incidence of ventricular arrhythmias. We
did not observe differences in the incidence of thromboem-
bolic complications or presence of significant mitral regurgi-
tation. Furthermore, TTS related to physical stress patients
had a worse ventricular function (“physical stress” left
ventricular ejection fraction 3912% versus “no stress”
4313% versus “emotional stress” 4312%; P=0.001).
Within the TTS group related to physical stress, we found a
higher incidence and severity of heart failure in the surgical group,
in addition to a higher incidence of ventricular arrhythmias.
Comparison of global and cardiovascular mortality at
90 days and 5 years among the different groups are shown
in Figures 1 and 2. An increased early mortality was observed
in the group with physical stress, whereas patients with
emotional stress-related TTS showed the most favorable
outcome. Interestingly, these findings persisted when analyz-
ing cardiovascular mortality. In the physical trigger subgroups,
the highest mortality was recorded in the hypoxia triggering
group, whereas the best prognosis was recorded in the
“extreme physical activity/trauma” and “sepsis” groups. In
the long-term follow-up, the slight trend toward a worse short-
term survival rate observed in physical TTS was statistically
consolidated (log-rank test, P<0.001). Within this group, the
worst survival rate was recorded in the hypoxia group.
The factors related to worse long-term prognosis are
presented in Table 3. No identifiable trigger and physical
triggers were noted as independent risk factors for 5-year
mortality using preceding emotional stressors as the reference
group (adjusted hazard ratio=1.9; 95% CI, 1.0–3.6; P=0.049
and hazard ratio=3.1; 95% CI, 1.8–4.3; P<0.001, respectively).
Sex (male), age >70 years, left ventricular ejection fraction
<30%, shock on admission, and diabetes mellitus were also
independent predictors of long-term mortality.
The long-term main causes of death were the following:
cardiovascular (33.0% of total deaths), infectious (21.2% of
total deaths), and neurological (15.1% of total deaths). We did
not observe relevant differences regarding cause of death
among the type of stress groups.
Discussion
The main findings of the present study can be summarized as
follows: (1) Short- and long-term prognosis depends on the
trigger of TTS; (2) patients with an emotional trigger have a
better prognosis, whereas those with physical stress have the
worst; (3) not all physical triggers influence the prognosis of
patients in the same way, with those triggered by hypoxia
presenting a worse evolution in the short and long term; (4)
incidence of physical, emotional, and unidentifiable triggers
are similar; and (5) age >70 years, shock on admission, left
ventricular ejection fraction <30%, and diabetes mellitus were
also independent predictors of mortality during the follow-up.
Initial studies had suggested that TTS is predominantly
preceded by emotional triggers.15,16 Subsequent studies have
proven that this syndrome may also be triggered by physical
factors or even without any evident preceding trigger.17–19
Some previous studies have shown that TTS related to
physical stress could have a worse prognosis.13,19,20 Recently,
a classification for TTS has been proposed based on its
possible prognostic implications.13 The reason for this
differentiation was to facilitate the identification and moni-
toring of phenotypes that could be related to a worse short-
and long-term prognosis. Our current data confirm this point,
showing a higher mortality in the group of TTS related to
physical stress and a better survival rate in the group with
emotional stress. In addition, our data add more information
regarding the different types of physical triggers that exist
showing a different prognosis. However, the reason for the
difference in mortality still remains unclear. Although several
hypotheses have been proposed to explain the mechanism of
TTS, catecholamine release by the central nervous system is
considered to have a central role in the pathophysiology of
TTS.2,21–23 Some researchers advocate for a differentiation in
the pathophysiological mechanism that triggers TTS. On the
one hand, emotional triggers may have a phasic nature, and
Table 3. Multiple Cox Regression for Long-Term Mortality
(5 Years)
HR (95% CI) P Value
Physical trigger* 3.073 (1.758–4.302) <0.001
No identifiable trigger* 1.913 (1.003–3.649) 0.049
Sex (male) 1.779 (0.925–3.419) 0.076




Significant mitral regurgitation 1.482 (0.732–3.001) 0.274
Shock on admission 2.048 (1.122–3.739) 0.020
Diabetes mellitus 2.750 (1.758–4.302) <0.001
Atypical type† 0.962 (0473–1.955) 0.915
HR indicates hazard ratio.
*No identifiable trigger and physical trigger were identified as independent risk factors
for 5-year mortality using preceding emotional stressors as the reference group.
†Based on transthoracic echocardiography. Atypical=midventricular type, basal type, or
focal type.
DOI: 10.1161/JAHA.119.013701 Journal of the American Heart Association 7


















 http://ahajournals.org by on January 25, 2021
wax and wane with the emotional state, whereas physical
triggers may chronically produce a catecholamine drive that
cannot be reduced without recovery from the underlying
disease. In fact, norepinephrine levels were higher in the
nonphysical trigger group.20
Many of the conditions that are related to the physical
triggers of TTS present variable prognoses that influence the
overall survival of patients. The case of a previously healthy
patient presenting TTS after a family discussion is completely
different from the patient who is admitted because of a septic
shock that develops TTS.
It is also important to identify comorbidities related to
some diseases that may influence the prognosis. In addition
to mortality attributable to these comorbidities, we might
consider as well the mortality related to TTS itself (that, in
these cases, may be higher because of the patient’s general
condition and which, ultimately, worsens the overall progno-
sis). Previous studies had shown a worse survival rate in
patients with TTS secondary to neurological disorders.23 This
is not surprising, given that the prognosis of these patients is
likely to be affected by the underlying disease. In other words,
the increased mortality in patients with neurological triggers
may result from the combined risk of TTS plus the intrinsic
risk of any precipitating comorbidity, such as cerebrovascular
hemorrhage. Unlike the previously published data, the worst
prognosis in our cohort was observed when the trigger was
hypoxia. When analyzing the baseline characteristics of these
patients, it is important to mention that they had a higher
prevalence of chronic lung disease, which could affect their
overall long-term survival. However, when we analyzed
cardiovascular mortality in this group, it was similar to that
recorded in the other subgroups where the trigger was
physical stress.
Our data show that the physical trigger also has an
important influence in the long-term prognosis. In addition,
other comorbidities, such as diabetes mellitus, age, and
ventricular function, were also shown as powerful predictors.
Recently, a meta-analysis was published in which these same
characteristics were identified as predictors of mortality in
TTS patients.24
Probably, differences in the short- and long-term prognosis
of TTS patients are the result of adding pathophysiological
differences that may exist among each of the triggers, as well
as the individual prognosis of each of the comorbidities. Our
data provide additional evidence to support the idea that
under the TTS label, there could be as yet undiscovered very
different clinical profiles, and therefore the perception of TTS
as having a benign prognosis should be questioned in general.
Moreover, in those TTS patients without a clear trigger, this
condition could indicate some form of increased cardiovas-
cular lability regarding the general population, explaining their
worse prognosis compared with emotional TTS forms.
Our study has some limitations. Because of its observa-
tional nature, unmeasured confounders could constrain
causal inference. However, prospective follow-up may permit
the application of the causal inference methods. By dividing
the group of physical stress into 5 different categories, the
number of cases within each variable was significantly
reduced, which could affect the statistical power of the
subgroup analysis. Although a 5-year follow-up analysis was
performed, there are a number of censored non-negligible
cases, as reflected by the median follow-up and subjects at
risk of survival analysis, so this should be taken into account
when analyzing the results. In order to be able to include in
the mutivariate analysis the largest number of patients,
although there were differences in some clinical variables
between groups (eg, type of chest pain, vegetative symp-
toms, etc), some of these variables were not included in the
multivariate analysis because they were not considered
potential confounders, and there are no previous studies
that have associated them with the prognosis of these
patients.
Conclusions
Patients with TTS related to physical stress could present a
worse short- and long-term prognosis in terms of mortality.
Therefore, these patients should be subject to thorough
surveillance and aggressive management not only during the
in-hospital stay, but also during outpatient follow-up as well,
given that this subtype is not so benign. It is important to
emphasize that not all physical triggers influence the prog-
nosis of patients in the same way, being that those whose
trigger is hypoxia are the ones presenting a worse evolution in
the short and long term.
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